Ipca Laboratories Limited is a leading pharmaceutical company headquartered in Mumbai, India. With over 75 years of experience, the company specializes in the development, manufacture, and marketing of a wide range of pharmaceutical products. Ipca Labs has a strong presence both in the domestic market of India and in several international markets. The company operates in multiple therapeutic segments, including anti-malarials, anti-inflammatory drugs, anti-diabetics, cardiovascular drugs, antibiotics, and more. It offers a diverse portfolio of branded and generic formulations, active pharmaceutical ingredients (APIs), and contract manufacturing services. Ipca Labs is known for its high-quality products, stringent quality control measures, and adherence to global regulatory standards.
- Ipca Laboratories Limited reported Total Income for Q4 FY23 of ₹1,548.02 Crore up from ₹1,303.64 Crore year on year, a growth of 18.7%.
- Total Expenses for Q4 FY23 of ₹1,418.58 Crore up from ₹1,134.09 Crore year on year, a growth of 25.1%.
- Consolidated Net Profit of ₹78.14 Crore, down 40.8% from ₹ 131.98 Crore in the same quarter of the previous year.
- The Earnings per Share is ₹3.02, down from ₹5.13 in the same quarter of the previous year.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,